Answers are grounded in this paper and cite their sources.
Purpose of review Histocompatibility is an important barrier to solid organ transplantation, but its role in kidney allocation remains controversial. This review summarizes some of the positive and negative aspects of histocompatibility in organ transplantation. Recent findings The importance of selecting more human leukocyte antigen (HLA)-compatible recipients for deceased donor kidneys has declined as the donor and recipient demographics have changed, and as the wait for transplants has grown in recent years. Although the overall difference in 10-year graft survival rates between the best and worst matched kidney transplants remains at about 18%, only about 15% of candidates can expect to receive a HLA-matched kidney. Larger gains in survival can be realized by matching donors and recipients more closely for age and other factors that are projected to increase the years of graft function for each deceased donor kidney. For many patients, however, who are sensitized against HLA antigens by pregnancies or previous graft failures, a more histocompatible organ is the only option for transplantation. Summary The utility of prospective HLA-matching in kidney allocation in the USA is being re-evaluated with a shift in the focus of the allocation system to better utilization of scarce deceased donor kidneys.
No takes yet. Share an insight, caveat, or question.
J. Michael Cecka (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: